FDA OKs Mixing COVID Vaccines; Backs Moderna, J&J Boosters

The FDA has approved COVID-19 booster shots for Moderna and Johnson & Johnson vaccines, allowing for mix and match options. This emergency approval aims to increase accessibility and speed up vaccinations. The CDC will provide further guidance soon. The Moderna booster is half the initial dose, and the mix and match strategy is designed to ease the process for those who may have had adverse reactions to their initial vaccine brand.

What significant change did the FDA make regarding COVID-19 boosters for Moderna and J&J vaccines?

• They approved boosters only for people over 65.

• They allowed mixing and matching of booster types.

• They restricted boosters to healthcare workers.

• They banned the use of J&J boosters.

What is the main difference between emergency approval and full authorization of vaccines?

• Emergency approval is permanent.

• Full authorization allows for more flexibility.

• Emergency approval allows for quicker adjustments.

• Full authorization is only for international use.

Who is eligible for the Moderna booster under the emergency approval?

• Only healthcare workers.

• Children under 18.

• Individuals 65 and older or 18-64 at higher risk.

• Anyone who received the Pfizer vaccine.

What is a potential benefit of mixing and matching COVID-19 vaccine boosters?

• It provides more accessibility and options for those with adverse reactions.

• It limits the availability of vaccines.

• It increases the number of required doses.

• It reduces the cost of vaccines.

Why might someone choose a different brand for their booster shot?

• To reduce the number of doses needed.

• To get a vaccine not approved by the FDA.

• To receive a higher dose.

• To avoid a previous adverse reaction.